These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 21210061)
21. Metallothioneins and synthetic metal chelators as potential therapeutic agents for removal of aberrant metal ions from metal-Aβ species. Xia N; Liu L Mini Rev Med Chem; 2014; 14(3):271-81. PubMed ID: 24456271 [TBL] [Abstract][Full Text] [Related]
22. Design of small molecules that target metal-A{beta} species and regulate metal-induced A{beta} aggregation and neurotoxicity. Choi JS; Braymer JJ; Nanga RP; Ramamoorthy A; Lim MH Proc Natl Acad Sci U S A; 2010 Dec; 107(51):21990-5. PubMed ID: 21131570 [TBL] [Abstract][Full Text] [Related]
23. Copper and zinc binding to amyloid-beta: coordination, dynamics, aggregation, reactivity and metal-ion transfer. Faller P Chembiochem; 2009 Dec; 10(18):2837-45. PubMed ID: 19877000 [TBL] [Abstract][Full Text] [Related]
24. Bifunctional backbone modified squaramide dipeptides as amyloid beta (Aβ) aggregation inhibitors. Dattatray Shinde S; Kumar Behera S; Kulkarni N; Dewangan B; Sahu B Bioorg Med Chem; 2024 Jan; 97():117538. PubMed ID: 38056379 [TBL] [Abstract][Full Text] [Related]
25. Metal ions, Alzheimer's disease and chelation therapy. Budimir A Acta Pharm; 2011 Mar; 61(1):1-14. PubMed ID: 21406339 [TBL] [Abstract][Full Text] [Related]
26. High-throughput analysis of Alzheimer's beta-amyloid aggregation using a microfluidic self-assembly of monomers. Lee JS; Ryu J; Park CB Anal Chem; 2009 Apr; 81(7):2751-9. PubMed ID: 19275225 [TBL] [Abstract][Full Text] [Related]
27. Interactions of Zn(II) and Cu(II) ions with Alzheimer's amyloid-beta peptide. Metal ion binding, contribution to fibrillization and toxicity. Tõugu V; Tiiman A; Palumaa P Metallomics; 2011 Mar; 3(3):250-61. PubMed ID: 21359283 [TBL] [Abstract][Full Text] [Related]
28. A multifunctional therapeutic approach: Synthesis, biological evaluation, crystal structure and molecular docking of diversified 1H-pyrazolo[3,4-b]pyridine derivatives against Alzheimer's disease. Umar T; Shalini S; Raza MK; Gusain S; Kumar J; Seth P; Tiwari M; Hoda N Eur J Med Chem; 2019 Aug; 175():2-19. PubMed ID: 31055149 [TBL] [Abstract][Full Text] [Related]
29. Copper(I) and copper(II) inhibit Aβ peptides proteolysis by insulin-degrading enzyme differently: implications for metallostasis alteration in Alzheimer's disease. Grasso G; Pietropaolo A; Spoto G; Pappalardo G; Tundo GR; Ciaccio C; Coletta M; Rizzarelli E Chemistry; 2011 Feb; 17(9):2752-62. PubMed ID: 21274957 [TBL] [Abstract][Full Text] [Related]
30. Alzheimer's disease, metal ions and metal homeostatic therapy. Zatta P; Drago D; Bolognin S; Sensi SL Trends Pharmacol Sci; 2009 Jul; 30(7):346-55. PubMed ID: 19540003 [TBL] [Abstract][Full Text] [Related]
31. Chelation and intercalation: complementary properties in a compound for the treatment of Alzheimer's disease. Cherny RA; Barnham KJ; Lynch T; Volitakis I; Li QX; McLean CA; Multhaup G; Beyreuther K; Tanzi RE; Masters CL; Bush AI J Struct Biol; 2000 Jun; 130(2-3):209-16. PubMed ID: 10940226 [TBL] [Abstract][Full Text] [Related]
32. Ability of selenium species to inhibit metal-induced Aβ aggregation involved in the development of Alzheimer's disease. Vicente-Zurdo D; Romero-Sánchez I; Rosales-Conrado N; León-González ME; Madrid Y Anal Bioanal Chem; 2020 Sep; 412(24):6485-6497. PubMed ID: 32322953 [TBL] [Abstract][Full Text] [Related]
34. Importance of the Dimethylamino Functionality on a Multifunctional Framework for Regulating Metals, Amyloid-β, and Oxidative Stress in Alzheimer's Disease. Derrick JS; Kerr RA; Korshavn KJ; McLane MJ; Kang J; Nam E; Ramamoorthy A; Ruotolo BT; Lim MH Inorg Chem; 2016 May; 55(10):5000-13. PubMed ID: 27119456 [TBL] [Abstract][Full Text] [Related]
35. Two pyridine derivatives as potential Cu(II) and Zn(II) chelators in therapy for Alzheimer's disease. Lakatos A; Zsigó E; Hollender D; Nagy NV; Fülöp L; Simon D; Bozsó Z; Kiss T Dalton Trans; 2010 Feb; 39(5):1302-15. PubMed ID: 20104357 [TBL] [Abstract][Full Text] [Related]
37. The metallobiology of Alzheimer's disease. Bush AI Trends Neurosci; 2003 Apr; 26(4):207-14. PubMed ID: 12689772 [TBL] [Abstract][Full Text] [Related]
38. Novel bis-(-)-nor-meptazinol derivatives act as dual binding site AChE inhibitors with metal-complexing property. Zheng W; Li J; Qiu Z; Xia Z; Li W; Yu L; Chen H; Chen J; Chen Y; Hu Z; Zhou W; Shao B; Cui Y; Xie Q; Chen H Toxicol Appl Pharmacol; 2012 Oct; 264(1):65-72. PubMed ID: 22842334 [TBL] [Abstract][Full Text] [Related]
39. Multiple function fluorescein probe performs metal chelation, disaggregation, and modulation of aggregated Aβ and Aβ-Cu complex. Muthuraj B; Layek S; Balaji SN; Trivedi V; Iyer PK ACS Chem Neurosci; 2015 Nov; 6(11):1880-91. PubMed ID: 26332658 [TBL] [Abstract][Full Text] [Related]
40. Inhibition of amyloid-β aggregation by coumarin analogs can be manipulated by functionalization of the aromatic center. Soto-Ortega DD; Murphy BP; Gonzalez-Velasquez FJ; Wilson KA; Xie F; Wang Q; Moss MA Bioorg Med Chem; 2011 Apr; 19(8):2596-602. PubMed ID: 21458277 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]